ImmunoGenix
San Diego, United States· Est.
ImmunoGenix focuses on developing novel immunotherapies and antibody-based treatments for autoimmune diseases and cancer.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $175M
About
ImmunoGenix focuses on developing novel immunotherapies and antibody-based treatments for autoimmune diseases and cancer.
ImmunologyOncologyAntibodies
Funding History
1Total raised:$175M
Series C$175M